References
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. Lyon: IARC Press; 2007.
- van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 2007;6:421–30.
- Compton JJ, Laack NN, Eckel LJ, et al. Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg 2012;117:825–30.
- Luyken C, Blümcke I, Fimmers R, et al. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 2004;101:146–55.
- Southwell DG, Garcia PA, Berger MS, et al. Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery 2012;70:1406–13 (discussion 1413–4).
- Bonney PA, Glenn CA, Ebeling PA, et al. Seizure freedom rates and prognostic indicators following resection of gangliogliomas: a review. World Neurosurg 2015;84:1988--96.
- Englot DJ, Berger MS, Barbaro NM, Chang EF. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia 2012;53:51–7.
- Selvanathan SK, Hammouche S, Salminen HJ, Jenkinson MD. Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database. J Neurooncol 2011;105:539–45.
- Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470–2.
- Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55:475–82.
- Wieser HG, Blume WT, Fish D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001;42:282–6.
- Huang C, Li H, Chen M, et al. Factors associated with preoperative and postoperative epileptic seizure in patients with cerebral ganglioglioma. Pak J Med Sci 2014;30:245–9.
- Lucas JT Jr, Huang AJ, Mott RT, et al. Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol 2015;123:171–7.
- Majores M, von Lehe M, Fassunke J, et al. Tumor recurrence and malignant progression of gangliogliomas. Cancer 2008;113:3355–63.
- Pallud J, Capelle L, Huberfeld G. Tumoral epileptogenicity: how does it happen? Epilepsia 2013;54:30–4.
- Pallud J, Audureau E, Blonski M, et al. Epileptic seizures in diffuse low-grade gliomas in adults. Brain 2014;137:449–62.
- Sommer B, Wimmer C, Coras R, et al. Resection of cerebral gangliogliomas causing drug-resistant epilepsy: short- and long-term outcomes using intraoperative MRI and neuronavigation. Neurosurg Focus 2015;38:E5.
- Pace A, Villani V, Di Lorenzo C, et al. Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neurooncol 2013;111:83–6.
- Sizoo EM, Braam L, Postma TJ, et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neurooncology 2010;12:1162–6.
- Pallud J, Le Van Quyen M, Bielle F, et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med 2014;6:244ra89.
- Aronica E, Boer K, Becker A, et al. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 2008;151:272–92.
- Conti L, Palma E, Roseti C, et al. Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Epilepsia 2011;52:1635–44.